Integra LifeSciences says Stuart Essig appointed as next CEO

Integra LifeSciences (IART) announced that Stuart Essig, chairman of Integra’s Board of Directors, has been appointed president and CEO, effective May 1. Essig will continue to serve as chairman. He succeeds Mojdeh Poul who is pursuing other opportunities. The company also announced that Michael McBreen, currently executive vice president, president, Codman Specialty Surgical, has been appointed chief commercial officer. Essig brings more than thirty years of experience in the medical technology and healthcare industries and has deep familiarity with Integra, having served as chairman of the board since June 2012 and as a director since 1997. He previously served as Integra’s chief executive officer from 1997 through early 2012, and as its President from 1997 until 2010. Over the past two years, Mr. Essig has been actively engaged in the business through his executive chairman role, with direct involvement in key company priorities as well as operational and quality matters.